Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys
Share |

FDA Finalizes Guidance on Distribution of Reprints
Clarifies How Manufacturers Can Hand Out Journal Articles to Docs

JournalsThe FDA recently finalized its "Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices U.S."

"There is a more defined line which manufacturers and companies can look at and figure out, 'how can I make this work for me and how can I make this work for my company,''' says Erin Reilly Lewis, Esq., counsel with Baker and Daniels in Indianapolis.

This guest article written by Michelle Leppert, Managing Editor, HCPro, Inc., outlines the major provisions of FDA's reprint guidelines.

Topic headings include:

  • Requirements in the guidance
  • Appropriate information
  • Off-label promotion still prohibited
  • Financial disclosures
  • Industry need for guidance

Read this article now. It's FREE...

Download PDF file

PMN81-03
Issue: Vol. 8, No. 1: January 2009
Word Count: 1041

Find other articles in related Topic Areas:

Vol 8, #1 Contents








Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.